describe a novel poliovirus chimera that expresses Gaussia luciferase (GLuc) inserted into 47 the polyprotein between P1 and P2 (N 2 H-P1-GLuc-P2-P3-COOH). This chimera, termed 48 PV-GLuc, replicated to 10% of wt yield. The reporter signal was fully retained for three 49 passages, and then gradually lost. After six passages the signal was barely detectable. On 50 further passages, however, the GLuc signal reappeared, and after eight passages it had 51 reached the same levels as observed with the original PV-GLuc at the first passage. We 52 demonstrated that this surprising observation was due to co-evolution of defective 53
Experiments with PV-GLuc revealed that the luciferase gene and its intracellular 103 expression were retained for three passages but then gradually lost. On further passage, however, 104 the GLuc signals reemerged, and eventually reached the same level as observed with the original 105 PV-GLuc during the first passage. We found that this was due to the co-evolution of two kinds of 106 replicating genomes: (a) wild-type (wt)-like genomes (P1-P2-P3), the helper viruses, with most 107 or all of the GLuc gene deleted and (b) genomes lacking much of the P1 coding sequence but 108 containing a complete GLuc gene. The latter evolved to form defective interfering (DI) particles 109 that are only rarely formed in the life cycle of poliovirus in tissue culture (48, 70) . 110
During enterovirus infection, host cells undergo metabolic and morphological alterations 111
that are induced by diverse functions of viral nonstructural proteins. Most dramatic are the 112 inhibition of cellular protein and cellular RNA synthesis, the rearrangement of existing 113 cytoplasmic membranous structures and the de novo synthesis of new vesicles (6, 9-11, 18, 55, 114 56, 58) . In addition, the viruses induce a large number of changes in the host cell that are 115 designed to favor viral replication and, at the same time, paralyze host cell defense mechanisms 116 (1, 42, 56) . 117
One of the profound changes induced by enterovirus infection is the inhibition of protein 118
secretion (23, 24, 41) . For example, infection of COS-1 cells with enteroviruses such as 119 poliovirus or Coxsackie B virus (CVB3) or the individual expression of enterovirus proteins in 120 target cells (e.g., 3A or 2B/2BC) blocks endoplasmic reticulum (ER) to Golgi traffic and results 121 in the inhibition of cellular protein secretion (23, 24, 64) . Interestingly, it was shown that CVB3 122 3A inhibits transport by binding to cellular factor GBF-1 and inhibiting GBF-1 dependent COP-1 123 recruitment to membranes (43, 44) . Polypeptides 3A and 2B and their precursors, 3AB and 2BC, 124 contain hydrophobic trans-membrane regions that play a role in their effect on secretion (2, 26, 125 62) . In the case of foot and mouth disease virus (FMDV), a picornavirus of the genus 126 Aphthovirus, the 2BC precursor polypeptide rather than 3A or 2B is responsible for the block in 127 the secretory pathway (43, 44) . 128
As expected, secretion of the GLuc protein from PV-GLuc infected cells was inhibited. 129
In experiments designed to pinpoint the PV proteins responsible for the block of GLuc secretion, 130
we made the surprising observation that individually 3A, 2B, 2C, 2BC, and 3AB had either no or 131 only a slight inhibitory effect on secretion in HeLa cells. This is different from reports of 132 inhibition of protein secretion from COS-1 cells (23, 24) . However, it was confirmed that GLuc 133 is not secreted from COS-1 cells if co-expressed with the PV 3A polypeptide. Therefore, we 134 suggest that the mechanism of GLuc secretion may be different in different cells types. In HeLa 135
cells, inhibition appears to be the result of interaction between several viral and cellular proteins; 136 thus the biochemical properties of one or more of the HeLa proteins may be distinct from those 137 of COS-1 or other tissue culture cells. Although Gluc does not have the advantage of being a 138 secreted protein in PV Gluc-infected cells, this reporter virus promises to be a useful tool in 139 studies of RNA replication and morphogenesis because of its increased genetic stability. 140
141

MATERIALS AND METHODS 142 143
Cell culture. HeLa R19 and COS-1 cell monolayers were maintained in Dulbecco's 144 modified eagle medium (DMEM) supplemented with 10% bovine calf serum (BCS), 100 U/ml 145 of penicillin, and 100 µg/ml of streptomycin. All cells were grown at 37°C in a 5% CO 2 146 incubator. 147
Plasmids. (i) pCMV-GLuc. pCMV-GLuc, containing the GLuc coding sequence, was 148 purchased from New England Biolabs (NEB). 149
(ii) pPV-GLuc. The pPV-GLuc plasmid was constructed from pT7PVM, which contains 150 the cDNA of type 1 poliovirus [PV1(M)]. The GLuc coding sequence was inserted between the 151 P1 and P2 domains of the PV polyprotein. The P1 domain was linked at its N-terminus to a 152 linker of 27 nt encoding an ENLTTY amino acid sequence. At its C-terminus the P1 domain was 153 fused to a linker of 9 nt (GGAGAATTC; EcoR I site) followed by the GLuc coding sequence. 154
The C-terminus of GLuc was fused to a modified FMDV 2A sequence (63 nt) terminated with 155 the amino acid sequence ELTTY, which forms a PV 2A pro cleavage site together with the first 156 amino acid (G) of P2. 157 (iii) Dicistronic reporter plasmids. pCMV-T7-GFP/viral protein-HG plasmids contain 158 the CMV promoter and the T7 RNA polymerase promoter linked to any of the following protein 159 coding sequences followed by a termination codon: PV 3A, PV mutant 3A (first 10 amino acids 160 deleted), or eGFP. The second cistron contains the GLuc and the FMDV 2A coding sequences 161 and a termination codon. Between the two cistrons, the HCV IRES was inserted. The non-162 translated region and the poly (A) signal at the 3'end were derived from plasmid pCMV-GLuc 163 (NEB). 164 (iv) Tricistronic reporter plasmids. pCMV-3A-EMCV IRES-GFP/viral protein-HG 165 plasmids contain the CMV and T7 RNA polymerase promoters linked to PV 3A. The second 166 cistrons contain any of the following protein coding sequences followed by a termination codon: 167 2B, 2C, 2BC, or eGFP. An EMCV IRES was inserted between PV 3A and the second cistron. 168
The third cistron contains the GLuc sequence and a termination codon. Between the second and 169 the third cistrons the HCV IRES was inserted. The non-translated region and the poly (A) signal 170 at the 3'end were derived from plasmid pCMV-GLuc. 171
Virus growth. Viruses were amplified by infection of HeLa R19 cell monolayers with ≥5 172 plaque forming units (PFU) per cell. Infected cells were incubated in DMEM (1% BCS) at 37°C 173 until a complete cytopathic effect (CPE) was detected. After three rounds of freezing and 174 thawing, the lysate was clarified of cell debris by a brief high-speed centrifugation and the 175 supernatant containing the virus was used for further passaging or reinfection. 176 DNA transfection. Plasmid DNAs (1 µg per transfection) were introduced into HeLa or 177 COS-1 cells growing in 12-well dishes using Lipofectamine transfection reagent (Invitrogen) 178 according to the manufacturer's instructions. After 3 to 4 h at 37°C, DMEM was replaced with 1 179 ml fresh DMEM containing 10% BCS, and incubation was continued overnight. At different 180 time points, samples of the growth medium and cell lysates were analyzed for luciferase activity. 181
For quantitation of GFP expression, a fluorescence image was taken at 24 hr post transfection. 182
In vitro transcription and RNA transfection. Templates for different viral RNAs were 183 cut by EcoR I or Dra I followed by phenol/chloroform extraction and ethanol precipitation. 184
About 1 µg of purified template was transcribed by T7 RNA polymerase (Stratagene) and the 185 integrity of the RNAs was examined by agarose gel electrophoresis. Between 10 and 15 µl of 186 fresh transcription reaction, containing between 1 and 10 µg of transcript RNA, was used to 187 transfect HeLa R19 cells on a 35-mm-diameter plate by the DEAE-Dextran method as described 188 previously (63). After a 30-min incubation at room temperature, the supernatant was removed 189 and the cells were incubated at 37°C in 2 ml of DMEM containing 1% BCS until CPE appeared. 190 Virus titers were determined by a standard plaque assay on HeLa R19 cell monolayers using a 191 semi-solid overlay of 0.6% tragacanth gum (Sigma-Aldrich) in minimal Eagle's medium. Western blot analysis. HeLa and COS-1 cells in 12-well culture plates were harvested 216 24 hr after transfection and lysed with PLB. The cell lysates were subjected to sodium dodecyl 217 sulfate-polyacrylamide gel electrophoresis (14% or 17% acrylamide). The proteins were 218 transferred to a nitrocellulose membrane (Roche) and were immunoblotted according to standard 219 protocols. The efficiency of transfer was verified by using pre-stained molecular weight markers 220 (Crystalgen). The resulting membranes were blocked for at least 60 min in a solution of 1% non-221 fat milk powder and 0.01% Tween-20 in Tris-Buffered Saline (TBS) at room temperature. After 222 blocking, the blots were incubated with different antibodies (α−2B, α−2C, or α−3A) overnight at 223 4°C. The blots were then washed five times for 5-15 min each in TBS containing 0.01% Tween-224 20 and incubated with an anti-mouse horseradish peroxidase-conjugated secondary antibodies 225
(1:10,000 dilution in TBS containing 0.01% Tween-20) for 1 h at room temperature. After five 226 washes, the immune complexes with bound secondary antibodies were detected by enhanced 227 chemiluminescence (ECL kit, Roche) according to the manufacturer's instructions. 228
229
RESULTS
231
Construction of a recombinant poliovirus expressing Gaussia luciferase. We 232 previously analyzed the properties of a reporter poliovirus that contains the Renilla luciferase 233 (RLuc) gene between the 5'-non-translated region (NTR) and the capsid protein precursor P1 234 (RLuc-P1-P2-P3). This construct has proven useful for distinguishing between defects in RNA 235 replication or encapsidation (37); however, the RLuc reporter gene was progressively deleted 236 after the first passage. Numerous other studies have already shown that PV does not efficiently 237 encapsidate RNAs containing inserts greater than 400 nt (3, 39, 41, 46, 72) . Therefore we assume 238 that the RLuc gene, which is 933 nt long, was deleted because of its size. 239
Recently, a smaller luciferase protein encoding gene, GLuc (555 nt, encoding 185 amino 240 acids), was discovered in the marine copepod Gaussia princeps; the protein encoded by GLuc is 241 naturally secreted (57). With the aim of constructing a more stable reporter virus, we have 242 constructed PV genomes containing the GLuc gene. Fusion of GLuc to the N-terminus of the 243 polyprotein (GLuc-P1-P2-P3) yielded a non-viable virus (data not shown), which we believe was 244 due to the peculiar and as yet unexplained observation that poliovirus polyproteins with an N-245 terminal signal sequence yield a dead phenotype (39). Although the GLuc protein contains a 246 natural secretory signal that has been shown to be effective in directing secretion (35), we 247 wondered whether this signal would be inhibitory within the polyprotein. Accordingly, we 248 inserted a codon use-optimized gene of the GLuc (57) between the P1 and P2 domains of the PV 249 polyprotein (P1-GLuc-P2-P3). In this pPV-GLuc construct, the reporter sequence is flanked by 250 two in-frame linkers: PV 2A pro and foot-and-mouth disease virus (FMDV) 2A pro protease 251 cleavage sites at the N-and C-termini, respectively (Fig. 1A) . GLuc produced by proteolytic 252 processing of this fusion polyprotein is predicted to contain three additional amino acids at the 253 N-terminus and 21 additional residues at the C-terminus compared to the wt protein. These 254 extensions did not alter GLuc activity (data not shown). 255
RNA replication and growth phenotypes of PV-GLuc. Transfection of transcripts of 256
pPV-GLuc into HeLa cells yielded a strong fluorescence signal in the cell medium at 16 hr (the 257 signal was weaker at 5 hr). The signal was abolished when 2 mM guanidine hydrochloride 258 (GnHCl), an inhibitor of PV RNA replication (53), was added post-transfection (data not shown). 259
These results indicated that RNA translation and replication delayed release of GLuc into the 260 medium, as would be expected if the non-structural proteins of PV-GLuc inhibited GLuc 261 secretion, and the discharge of GLuc occurred only at the onset of cell lysis (see below). 262
To compare the growth phenotype of virus expressing GLuc with that of wt PV we 263 transfected HeLa cells with transcript RNAs of both viral genomes. Cytopathic effects were 264 apparent with wt PV transcripts at 18-20 hr post-transfection but were barely detectable with PV-265
GLuc transcripts at 40 hr post-transfection (data not shown). However, PV-GLuc isolated from 266 passage 1 (P1) exhibited a small plaque phenotype (Fig. 2B ) and, at multiplicity of infection 267 (MOI) of 5, replicated with a viral yield one log below that of the wt virus when tested in a one-268 step growth experiment (Fig. 1B) . Quantitative RT-PCR analyses indicated that the primary 269 reason for the lower yield of PV-Gluc virus when compared to that of the wt virus is a reduction 270 in the total number of RNA genomes synthesized (Fig. 1C) . Intracellular synthesis of GLuc, as 271 determined by analysis of cell lysates (Fig. 1D) , paralleled the time course of virus production 272 (Fig. 1B) . The weak reporter signal in the growth medium during the first several hours after 273 infection indicated potent inhibition of GLuc secretion (Fig. 1D ). At 9 hr post infection, 274 however, some GLuc appeared in the medium, most likely due to cell lysis (Fig. 1D) . 275
Genetic stability of PV-GLuc. Although the GLuc coding sequence in PV-GLuc is 276 relatively small, we expected that it would be eventually eliminated, as it presents no advantage 277
to virus replication. We tested this hypothesis by assaying for GLuc activity after each of 278 multiple successive passages on HeLa cells using an MOI of 5 ( Fig. 2A) . Although stable for the 279 first three passages, the GLuc signal diminished at the fourth passage (P4), and was nearly 280 undetectable by the sixth passage (P6). These results suggest that the reporter gene was 281 progressively eliminated from the genome, presumably by deletion. Remarkably, however, the 282
GLuc signal returned to high levels by P9 and remained stable for more than 12 consecutive 283 passages. This unexpected phenomenon was observed in two independent experiments (data not 284 shown). The plaque size of the progeny virus was small after the first passage, most probably due 285
to the large size of original reporter genome, but developed into a mixture of plaques sizes after 286 P8, suggesting the presence of shortened genomes, nearly wt in size, that produced large plaques 287 (Fig. 2B) . 288
Characterization of defective interfering particles obtained during passaging of PV-289
GLuc on HeLa cells. To determine how PV-GLuc genomes were altered to lead to the 290 fluctuation of the GLuc signal, we performed RT-PCR of total cellular/viral RNA with primers 291 amplifying the entire coding sequence of P1, and that of the GLuc sequence. The sizes of the 292 PCR fragments as analyzed by agarose gel electrophoresis indicated that the P1-GLuc fragment 293 was intact for the first 2-3 passages (Fig. 3A; compare lanes 1 and 2) . After P4, the amount of 294 the full-length P1-GLuc segment was much reduced, and smaller fragments appeared (Fig. 3B,  295 compare lane 2 with lanes 4 to 6). 296
The products obtained from P6, P9, and P21 were primarily of two sizes (Fig. 3B, lanes  297 4 to 6). The DNA fragments were sub-cloned into vectors, amplified, and subjected to sequence 298 analysis. The larger fragment that was produced at P6, P9, and P21, revealed that essentially all 299 of the GLuc coding sequence and some linker sequences were deleted. We concluded that these 300 fragments represent the sequences of newly generated helper virus (wt-like PV) (Fig. 4; Table 1) , 301 which provides the capsid proteins necessary for encapsidation in the progeny mixture. Since the 302 helper virus had lost the intact GLuc gene, no Gluc activity was associated with any of these 303 infectious particles. The size of the smaller fragments (Fig. 3B ) was consistent with genomes 304 containing different deletions. Indeed, sequence analysis revealed a heterogeneous population of 305 variants containing different deletions either in P1 (DI particles 5, 6, 8, 9) or in both P1 and 306
GLuc (DI genomes 1-4, 7, 10, 11). Deletions in the P1 region ranged in size from 1503 to 2013 307 nts (Fig. 4, Table 1 ). These fragments that contained the entire GLuc coding domain originated 308 from variants that produce the GLuc signal. Deletions in both P1 and GLuc ranged in size from 309 1779-1923 nts. DI variants containing such deletions likely lack GLuc activity. Quantitative RT-310 PCR analyses indicated that at P8, P9 and P21 the progeny mixture contained 60%, 55% and 311 70% DI particles, respectively (Fig. 3C) . 312
Interestingly, the small fragment isolated from P6 and P9 was about 1.6 kb in length, but 313 by P21 the length that has evolved among the genotypes increased to 1.9 kb (Fig. 3B) . Three out 314 of four DI genomes examined from P21 contained the shortest deletion observed (1503 nts, 315 Table 1 , small fragment #11). This suggests that after long-term passaging, the DI genome length 316 that evolved was optimized for encapsidation in trans and RNA replication rate. Increase in 317 replication rate, which is essential for DI particle survival, may be the reason for a DI genome 318 nearly one thousand nucleotides shorter than that of wt PV RNA. Sequences missing from the 319 longest DI genome characterized were regions of P1, the C-terminal linker sequence, and the N-320 terminal four amino acids of the GLuc gene originally inserted into the PV polyprotein. 321
To confirm the genotypes of the stable DI genomes after P21, we separated the DI 322 particles from the helper virus on a CsCl gradient (data not shown). The RNA of the DI particles 323 isolated from the upper weak bands of the gradient was then subjected to RT-PCR. Sequencing 324 of the PCR fragments indicated the presence of two types of DI particles, one containing the 325 previously observed deletion of 1503 nts ( Fig. 4B ; Table 1 ; DI genome #11), and the other a 326 deletion of 1380 nts that had not been detected in previous analyses ( Fig. 4B ; Table 1 ; DI 327 genome #12). Both DI genomes should produce the GLuc signal. The identity of the helper virus 328 isolated from the lower band of the gradient was also confirmed by sequencing of the N-terminus 329 of the P1 domain that was fused to a linker containing heterologous sequences (27 nts, Fig. 1A) . 330
As expected from previous studies of PV DI particles, all of the DI RNA derived from 331 our reporter virus contained in-frame deletions and, thus, intact reading frames for the synthesis 332 of the nonstructural proteins (Table 1) . Intact translation is a requirement for replication, and, 333 thus, out-of-frame deletions are eliminated from the pool of competing genomes (48). 334
The ability of DI particles to interfere with the growth of wt poliovirus was first studied 335 in detail by Cole and his colleagues (13, 14) . Our experiments confirm this phenomenon. As 336 shown on Fig. 4C , there is a nearly 8 fold reduction in virus titer between passages P6 and P21 337 of PV Gluc on HeLa cells, presumably as a result of increasing number of DI particles produced. 338
We obtained additional proof for interference by DI particles using cotransfection of wt PV and 339 DI genome #11 transcript RNAs, at ratios 1:0 to 1:10, into HeLa cells and measurement of virus 340 titers at the time of CPE. The results clearly indicate that virus titers decreased as a result of 341 increasing the DI particle production, demonstrated by an increase in luciferase signal (Table 2) . 342
Co-expression of PV polypeptide 3A with GLuc in HeLa cells does not inhibit 343 secretion of luciferase. Previous studies have shown that infection of COS-1 cells with PV or 344
expression of PV protein 3A inhibits the transport of secretory proteins in these cells (24). The 345 N-terminal 10 amino acids of 3A (deleted in a mutant 3A) have been shown to be involved in 346 this block of secretion (23). Since PV infection inhibited secretion of GLuc from HeLa cells 347 (Fig. 1D) , we assumed that PV 3A would also inhibit GLuc secretion in HeLa cells, as it does in 348 COS-1 cells. This was not so. To test secretion of GLuc in the presence of 3A, we constructed a 349 dicistronic expression vector (Fig. 5A) (Fig. 5B) or from COS-1 cells (Fig. 5C ) 357
were measured at 24 hr post-transfection. The expression of the 3A proteins was monitored by 358 western blot analysis (Fig. 5D) , whereas the expression of eGFP was visualized by fluorescence 359 microscopy (Fig. 5E ). As shown in while 3A and 3AB are anchored through hydrophobic sequences (26, 51, 62, 64) . Previous 371 studies in Vero cells infected with FMDV have shown that 2BC (or co-expression of 2B and 372 2C), but not 3A, inhibits ER to Golgi protein transport (43). Therefore we made dicistronic 373 constructs in which the first cistron contained the coding sequences of 2B, 2C, 3AB, or 2BC 374 (Fig. 6A) . As a control, eGFP was also engineered into the first cistron. Plasmid DNAs were 375 transfected into HeLa (Fig. 6B ) and COS-1 (Fig. 6C ) cells, and GLuc activity in cell lysates or in 376 the medium was measured as described above. The expression of proteins was monitored by 377 western blot analysis (Fig. 6D) . As shown in Fig. 6B , secretion of GLuc was as efficient in the 378 presence of 2B, 2C, or 3AB as in the presence of the eGFP protein. Expression of 2BC resulted 379 in a slight inhibition of GLuc secretion. In comparison, in COS-1 cells (Fig. 6C) , all of the 380 proteins showed partial inhibition of GLuc secretion when compared to expression of the control 381 protein. In COS-1 cells the strongest inhibitory effects (>50%) were seen with 2B and 2BC, 382 although these were less striking than what was observed with 3A (compare Figs. 5C and 6C) . we were interested to know whether a combination of two poliovirus non-structural proteins 387 (e.g., co-expression of 3A with 2B, 2C, or 2BC) would influence secretion of the luciferase 388 protein. Therefore, we constructed tricistronic vectors, a strategy first described by Jang et al. 389 (31) . In our vectors, the first ORF encoded 3A, the second contained either a viral protein (2B, 390 2C, or 2BC) or the control eGFP protein, and the third encoded GLuc (Fig. 7A) . The translation 391 of 3A was cap dependent. Translation of the second and third cistrons was controlled by the 392 EMCV IRES and HCV IRES, respectively. The plasmid DNAs were transfected into HeLa or 393 COS-1 cells, and the GLuc signal was monitored at 24 hr post-transfection both in the growth 394 medium and the lysate. As shown in Fig. 7B , there was no significant difference in the secretion 395 of GLuc in HeLa cells when 3A was co-expressed with 2B, 2C, or 2BC or the control eGFP 396 protein. However, the results were different when COS-1 cells were used in the experiment (Fig.  397   7C) . Whereas 3A/eGFP and 3A/2B produced strong inhibition of secretion as expected, co-398 expression of 3A with 2C or 2BC mitigated the inhibitory effect (compare Figs. 5C and 7C) . 399
The expression of proteins was monitored by western blot analysis to ensure that the amounts of 400 proteins produced were comparable (Fig. 7D) . 401
Secretion of GLuc from HeLa cells occurs through the conventional ER to Golgi 402
pathway. To test whether GLuc was transported and secreted in HeLa cells through the 403 conventional ER to Golgi secretory pathway we tested the effect of Brefeldin A (BFA), a drug 404 that inhibits anterograde ER export to the Golgi. HeLa cells were transfected with plasmid for 405 expression of GLuc from the CMV promoter (Fig. 8A) . At 6 hr post-transfection BFA was added 406 over a range of concentration and the secretion of GLuc was assayed in the medium after 16 hr. 407 A striking reduction (>95%) of GLuc activity was observed in the presence of 1 µg/ml of BFA 408 (Fig. 8B) . These results confirm that the secretion of GLuc occurs by the conventional ER to 409
Golgi pathway (5, 52). We selected GLuc (555 nt, the smallest luciferase gene known) as the reporter, which in the 417 context of the PV genome was expected to be retained longer than the larger RLuc (933 nt). 418
Originally, we fused the GLuc sequence to the N-terminus of the PV polyprotein. The 419 corresponding genome, however, was non-viable. In retrospect, we should have expected this 420 result since we have shown previously that a signal sequence directing polypeptides to the rough 421 endoplasmic reticulum, when placed at the N-terminus of the poliovirus polyprotein, renders the 422 construct non-viable for unknown reasons (39). It should be noted that inactivating the signal 423 sequence of GLuc by deletion allowed its expression at the N-terminus of the PV polyprotein, 424
and rendered the engineered genome viable (data not shown). However, because of reports that 425 modifying the signal sequence of GLuc influenced its expression (57), we have not pursued these 426 experiments further. 427
We then inserted the GLuc ORF into the polyprotein between domains P1 and P2 (Fig.  428   1A) . The PV-GLuc virus replicated to high titers, albeit one log below that of wt PV. The GLuc 429 polypeptide is released from the polyprotein by two distinct proteolytic activities, PV 2A pro and 430 the autocatalytic 2A activity of FMDV. The released luciferase has additional amino acid 431 residues at its N-and C-termini, which did not inhibit production of a strong fluorescence signal. 432 PV-GLuc retained luciferase activity for three passages on HeLa cells; thus, the PV-GLuc 433 genome was significantly more stable than that of our original PV-RLuc construct (37). 434 Therefore, PV-GLuc is expected to be a useful tool in studies of enterovirus replication and 435
encapsidation. 436
Continued passaging of PV-GLuc beyond P3 led to the near complete loss of the GLuc 437 signal by P6. The signal was, however, completely recovered by P8. This unusual phenomenon 438 resulted from the co-evolution of virus variants of two different genotype groups: one resembling 439 wt-like viruses, the other resembling that of defective interfering (DI) particles. After 21 440 passages the predominant DI genomes were shorter than the original PV-GLuc genome by 1,380 441 nts or 1,503 nts but they retained, surprisingly, almost the complete coding sequence of GLuc. 442
The interpretation of our data does not exclude the possibility that numerous other genotypes 443 exist throughout passaging and even at P21 escape detection because of low abundance. The 444 genome sizes of 6,600-6700 nt (DI genomes #11 and #12) may be optimal for efficient 445 encapsidation and virion stability, a result consistent with data previously reported by Kuge and 446 colleagues (30) . We propose that the genotypes of these P21 genomes provide the DI particles 447 with the properties essential for their survival: a significantly higher rate of genome replication 448 compared with that of the wt-like helper virus and maximal efficiency of encapsidation with 449 capsid polypeptides "stolen" from wt-like virus. This is the reason for interference with the 450 growth of the wt virus by the DI particles, a phenomenon, which we have confirmed with one of 451 our DI particles derived from PV-GLuc ( Fig. 4C ; Table 2 ). 452 DI particles were discovered more than 60 years ago (28, 66), but their role in the 453 pathogenesis of viruses is poorly understood (30). The genomes of these particles always contain 454 deletions that spontaneously arise during virus replication, preferentially in infections at high 455 multiplicity. The DI variants competed with the wt-like variants for capsid proteins thereby 456 interfering with the replication of the latter. The deletions render the DI genomes non-infectious 457 but the defects are complemented in trans at the expense of homologous wild type helper 458 viruses. Poliovirus DI particles were first observed as contaminants in laboratory stocks (14), but 459 they are not readily generated in cell culture (70). Because poliovirus DI genomes replicate 460 efficiently it was assumed that the deletions map to the P1 region and not to the nonstructural 461
proteins. This was proven correct by heteroduplex mapping and biochemical procedures (48) . 462 Whereas deletions in DI genomes of PV type 1 Sabin, selected in tissue-culture 463 experiments, spanned between 4% to 16% of the wt genome (32), viable genetically engineered 464 deletions of PV type 1 (M) can be much larger, spanning nearly the entire P1 region (70). There 465 is evidence that a 20% reduction in genome size may represent the largest deletion compatible 466 with DI virion stability, and Nomoto and his colleagues made the important observation that 467 deletions in the P1 region must be in frame with the initiation codon at nt 743 in order for DI 468 genome replication to occur (15, 27, 36) . This has led to the discovery of the "secondary proof 469 reading mechanism" in picornavirus proliferation: Correct translation and processing of the 470 polyprotein is required for RNA replication, which, in turn, is required for encapsidation (45, 49, 471 50, 71) . presumably by different mechanisms (23, 24) . It was subsequently concluded that restricting 477 protein secretion does not impact intracellular viral replication per se but rather inhibits host 478 responses thereby stimulating viral infection (17, 19, 21, 64, 68, 69) . This is supported by the 479 observation by van Kuppeveld and his colleagues that a mutant of the CVB3 3A protein, inhibiting the function of GBF-1 (7, 67). 488 A failure to block protein transport by 3A or other small enterovirus proteins 489 corresponding to those of PV has been reported for many picornaviruses, such as hepatitis A 490 virus, enterovirus 71, Theiler's virus, and rhinovirus 14 (1, 12). In FMDV replication, the 2BC 491 polypeptide, rather than 3A or 2B, is responsible for the blockage of ER to Golgi traffic (43, 44) . 492
In view of the observed heterogeneity in protein structure of these small picornavirus proteins it 493 has been concluded that the mechanisms by which they exert their inhibition of protein secretion 494 must be different (1, 12) . On the basis of several studies reporting inhibition of protein secretion 495 by picornaviruses or picornavirus nonstructural proteins (8, 22, 23, 47, 67) , we expected that 496 GLuc would not be released from PV-GLuc-infected cells. This assumption was supported by 497 the data shown in Fig. 1D . However, extending these experiments to expression of proteins 3A, 498 2B, 3AB, and 2BC in HeLa cells individually or as pairs (3A/2B, 3A/2C or 3A/2BC), we did not 499 observe inhibition of secretion of GLuc. Indeed, GLuc was secreted from HeLa cells when co-500 expressed with 3A, a 3A mutant (that does not inhibit secretion), or eGFP (Fig. 5B) . In contrast, 501 in COS-1 cells, our results were consistent with previously published data since 3A robustly 502 inhibited secretion whereas the 3A mutant or eGFP did not (Fig. 5C) . Similar results were 503 obtained when 2B, 2C, 2BC, or 3AB were expressed individually with GLuc or when GLuc was 504 co-expressed with pairs of viral proteins 3A/2B, 3A/2C, or 3A/2BC (Fig. 7) . These results 505 suggest that the effect of 3A or 2B expression on GLuc secretion is possibly cell-type dependent. 506
At present we cannot explain the difference between the effect of PV infection and 507 expression of individual polypeptides on secretion of GLuc from HeLa cells. It is possible that 508 the entire complement of PV proteins encoded in the polyprotein is necessary for the inhibition 509 of secretion of GLuc from HeLa cells, and that this mechanism involves an additional set of 510 cellular proteins than the set interacting 3A, 2B, 2BC, or 3AB. Moreover, the sequence and/or 511 a: Wt/DI ratio is the molar ratio of RNA used for transfection into HeLa cells.
